Company Filing History:
Years Active: 2010
Title: Innovator Spotlight: Anna-Marja Hoffren
Introduction
Anna-Marja Hoffren, based in Raisio, Finland, is a notable inventor in the field of pharmaceuticals. With a strong focus on somatostatin receptor research, she has made a significant contribution to the development of targeted therapies.
Latest Patents
Anna-Marja holds a patent for the invention titled "Somatostatin receptor 1 and/or 4 selective agonists and antagonists". This innovation pertains to (hetero)arylsulfonylamino based peptidomimetics of a specific formula, which demonstrates high affinity and selectivity for the somatostatin receptor subtypes SSTR1 and SSTR4. These compounds can potentially be utilized in the treatment or diagnosis of various diseases where SSTR1 and SSTR4 interactions are relevant.
Career Highlights
Currently, Anna-Marja Hoffren is associated with Siegfried Wurster, a company known for its impactful work in the pharmaceutical sector. Her expertise in medicinal chemistry and receptor biochemistry has been pivotal in advancing therapeutic options for patients.
Collaborations
Throughout her career, Anna-Marja has collaborated with several talented individuals, including colleagues Jussi Tomperi and Paivi Hautamaki. These collaborations have fostered a dynamic environment for innovation, contributing to the development of high-quality pharmaceutical solutions.
Conclusion
Anna-Marja Hoffren’s innovative work significantly impacts the field of pharmacology. Her patent on selective agonists and antagonists for somatostatin receptors highlights her dedication to advancing medical science. As she continues her career, her contributions will undoubtedly enhance therapeutic approaches and improve patient outcomes.